BioAge Labs Inc.
Status: Publicly traded
Direct answer
BioAge Labs Inc. is publicly traded on NASDAQ under the ticker BIOA.
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in...
Can you invest in BioAge Labs Inc.?
Yes. BioAge Labs Inc. is publicly traded on NASDAQ under the ticker BIOA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BioAge Labs Inc.
Detailed equity research is provided by MarketSnap.